Author: FAZ, Mirna; MARTÍNEZ, José Simón; QUIJANO-HERNÁNDEZ, Israel; FAJARDO, Raúl
                    Title: Reliability of clinical diagnosis and laboratory testing techniques currently used for identification of canine parvovirus enteritis in clinical settings  Document date: 2016_11_6
                    ID: z3in6bi2_19
                    
                    Snippet: On the other hand, many veterinarians consider the presence of leukopenia, a supporting factor for CPV-2 diagnosis. However, we observed that only 48.8% (22/45) of the studied dogs presented leukopenia during evaluation, which is consistent with other reports that indicated around 50% of dogs don't display hematologic alterations at the time of evaluation [18] . Therefore, a CBC is a valuable tool that can provide information about the disease se.....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: On the other hand, many veterinarians consider the presence of leukopenia, a supporting factor for CPV-2 diagnosis. However, we observed that only 48.8% (22/45) of the studied dogs presented leukopenia during evaluation, which is consistent with other reports that indicated around 50% of dogs don't display hematologic alterations at the time of evaluation [18] . Therefore, a CBC is a valuable tool that can provide information about the disease severity, suggesting a prognosis and determining the response to treatment. However, leukopenia should not be considered as a diagnostic tool for CPV-2, because it does not provide an evidence for virus presence.
 
  Search related documents: 
                                Co phrase  search for related documents- diagnostic tool and evaluation time: 1, 2, 3, 4, 5, 6
  - diagnostic tool and treatment response: 1, 2, 3, 4
  - diagnostic tool and valuable tool: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
  - diagnostic tool and virus presence: 1, 2, 3, 4, 5
  - disease severity and evaluation time: 1, 2, 3, 4, 5
  - disease severity and prognosis suggest: 1, 2
  - disease severity and support factor: 1, 2, 3, 4
  - disease severity and treatment response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63
  - disease severity and treatment response determine: 1, 2
  - disease severity and valuable tool: 1, 2, 3, 4, 5, 6, 7, 8
  - disease severity and virus presence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
  - evaluation time and treatment response: 1, 2, 3, 4, 5, 6
  - evaluation time and valuable tool: 1, 2
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date